undamentalytics Newsletter

Compugen LTD balance sheet

At the end of fiscal 2025, Compugen LTD had total assets of $157m and shareholders' equity of $103m. It held $90.6m in cash against $0 of debt: net cash of $90.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Compugen LTD: balance sheet, annual
Fiscal year2009Dec 20092010Dec 20102012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162018Dec 20182020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Cash and equivalents157162926111067811141891
Receivables—0———8——2—0610—
Total current assets—2826537591634712912386115106148
Total assets—36295711599715313813294121115157
Accounts payable—1011213152422
Deferred revenue (current)———520————0111011
Total current liabilities—21877510111712262023
Total debt00000000000000
Shareholders' equity27281832106906437120107786655103
Net debt (negative = net cash)−15−7−16−29−26−11−10−6−7−8−11−14−18−91
Shares outstanding33m34m37m41m50m51m51m60m84m86m87m89m90m95m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CGEN vs VRDNCGEN vs WVEASMB vs CGEN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Compugen LTD's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Compugen LTD.